CDG Invest Growth invests in the capital of companies in Morocco and Africa

CDG Invest Growth exits Techniques Science-Santé (T2S)

14 décembre 2021

CDG Invest Growth announces the completion of its exit from Techniques Science-Santé (T2S) through a sale to a holding company owned by Helios investment fund.

CDG Invest Growth acquired a significant minority stake in T2S  in June 2016 through the Capmezzanine II fund.

Founded in 1992 by Mr. Abderraouf Sordo and his four partners, T2S has become, in less than three decades, the undisputed leader in the distribution and maintenance of medical equipment in Morocco and then in French-speaking Africa, with revenues of around 700 Mdhs in 2020. T2S’s success is the result of long-standing relationships with leading medical device manufacturers, as well as the trust and legitimacy it enjoys with its customers.

Click here for more information about T2S

January 2019 CDG Invest Growth, the private equity firm focused on growth investments for SMEs in Morocco, announced an investment in Laboratoires Steripharma (“Steripharma” or “the Company”), a well-established pharmaceutical business in Morocco. CDG Invest Grwoth has acquired a stake in the Company from several minority shareholders. Steripharma was founded in 1999 and has since developed […]

We are thrilled to announce that the Association Marocaine des Investisseurs en Capital (AMIC) has appointed a new Board of Directors, which unanimously elected Mr. Hassan Laaziri as President. The members of the Board of Directors are now:

In December 2014, CDG Invest Growth exited JUICE AND NECTAR PARTNERS (JNP), the latest investment of the Accès Capital Atlantique Maroc S.A (ACAMSA) Fund.The withdrawal of JNP, a producer of organic juice mainly for export, was carried out to the benefit of the HOLMARCOM Group, a major operator in the Moroccan economy. This sale operation […]